Nrx pharmaceuticals receives us food and drug administration review of zyesami® (aviptadil) manufacturing information

Radnor, pa., nov. 11, 2021 (globe newswire) -- nrx pharmaceuticals (nasdaq: nrxp ), today announced receipt of the us food and drug administration's (fda) response to nrx's october 8 submission of updated manufacturing information for zyesami® (aviptadil).

NRXP Ratings Summary

NRXP Quant Ranking